News & Statements

T1International Releases Report on Rationing and Cost Survey Data

18 Jun 2019, 8 a.m. in #insulin4all USA, News & Statements by T1International

Results found that dangerous and potentially fatal insulin rationing is widespread globally, with 18.0% of all country respondents having rationed insulin at least once in the previous year. It also found that respondents from the USA paid more by the dollar for insulin than almost any other country and that 25.9% of U.S. respondents reported having rationed insulin in the previous year. This confirms similar findings from previous smaller-scale surveys that one of every four people in the United States have had to ration insulin. Read more

T1International at the Democratic Caucus Prescription Drug Prices Roundtable

13 Jun 2019, 4:14 p.m. in #insulin4all USA, News & Statements by Adeline (Lina) Umubyeyi

I appreciated the platform that myself and T1International were given to share our experiences and our clear requirements for any proposed solutions. I hope we will soon see a reduction in insulin costs to ensure it is truly affordable for everyone, and that is what we will continue to push for. Read more

T1International’s Advocates Plan Canada Trip to “Birthplace of Insulin”

12 Jun 2019, 8:52 a.m. in #insulin4all USA, News & Statements by T1International

On Friday, June 28, T1International #insulin4all advocates from the United States, in partnership with Health Care Voter, will join in a Caravan to Canada to purchase insulin at a significantly lower cost on the other side of the border. Advocates from T1International’s Minnesota #insulin4all Chapter will gather in Minneapolis, Minnesota and begin their journey. From there, the Chapter will travel to Lansing, Michigan to join the Michigan #insulin4all Chapter, with advocates from numerous other #insulin4all Chapters joining the caravan along the way. Read more

T1International at the UN UHC Multi-stakeholder Hearing

17 May 2019, 12:31 p.m. in Global Stories, News & Statements by Lauren Lehrer & Karlynn Holland

In particular, we call on pharmaceutical companies to show up with true solutions, not the same empty rhetoric. We are dying. There are solutions. It is times to protect rights of health and treatment for people living with diabetes and all those in desperate need of essential medicine – a vital part of health for all. Read more

T1International Statement on Lilly & Novo's ''Generic Insulin''

4 Mar 2019, 2:32 p.m. in #insulin4all USA, News & Statements by T1International

Patient-led activism is working. Today Eli Lilly announced that in response to criticism of high prices, the company will sell a version of Humalog insulin for half price. We are pleased to see this result after continual and dedicated efforts by non-pharma funded patient advocates to ensure list price of insulin goes down. While half-price is an improvement, it's still an unaffordable price for so many, considering most people need at least 2 vials each month.
Read more

Hard Work Pays Off for #insulin4all Chapters [USA Update]

27 Feb 2019, 9:56 a.m. in #insulin4all USA, News & Statements by T1International

The #insulin4all USA Chapters are building a coordinated movement to ensure insulin is affordable and accessible to all people with type 1 diabetes. Their efforts are leading to real change at both the State and Federal level. Read more

#insulin4all Petition Leads to Prescription Drug Pricing Bill for Indiana General Assembly

1 Feb 2019, 5:59 p.m. in #insulin4all USA, News & Statements by T1International

Last month, Hoosiers living with type 1 diabetes delivered to the Indiana General Assembly a petition signed by over 500 people demanding that the House Public Health Committee hear a bill to establish a study committee on rising prescription drug prices. Their efforts have paid off. Committee Chair Rep. Cindy Kirchhofer has set the legislation, House Bill 1029, for hearing on Wednesday, February 6th at 3:30 PM in the House chamber. Read more

T1International Expands USA #insulin4all Work

28 Jan 2019, 8:43 a.m. in #insulin4all USA, News & Statements by T1International

T1International is excited to announce the expansion of our USA work to address the insulin price crisis in America. Thanks to a grant from the Laura and John Arnold Foundation (LJAF), we have brought on board a US Program Manager consultant to help us build our grassroots State Chapters and give people with type 1 diabetes a stronger presence in policy-making. Read more

T1International Statement on Novo Nordisk and Sanofi Price Hikes

10 Jan 2019, 6 p.m. in #insulin4all USA, News & Statements by T1International

Sanofi and Novo Nordisk are celebrating the New Year with fresh price hikes on their decades-old insulin products. “Sanofi increased the price of its three main insulin brands by between 4.4 %- 5.2 % last week, while Novo Nordisk increased the price of its insulin products by just under 5% on Tuesday,” the Financial Times article said. Once again, shareholder profits will be increased on the backs of people with diabetes. Read more

Hoosiers with Diabetes Petition Indiana General Assembly to Study Drug Pricing

2 Jan 2019, 4:18 p.m. in #insulin4all USA, News & Statements by T1International

Hoosiers living with Type 1 diabetes today delivered to the Indiana General Assembly a petition signed by over 500 persons demanding that the House Public Health Committee hear a bill to establish a study committee on rising prescription drug prices. The petition was delivered to House of Representatives Public Health Committee Chair Rep. Cindy Kirchofer and all of the committee members. Read more